FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969767511> ?p ?o ?g. }

• W1969767511 endingPage "2681" @default.
• W1969767511 startingPage "2673" @default.
• W1969767511 abstract "The “Fab immunogene” is a novel gene transfer vehicle in which the Fab fragment of anti-human epidermal growth factor (EGF) receptor antibody B4G7 is conjugated with poly-l-lysine to form an affinity complex with DNA. It was developed to target delivery of therapeutic genes into EGF receptor-hyperproducing tumor cells. Various characteristic features of the immunogene have been documented (Chen et al., 1998). Here we add further evidence to prove that in vitro transfer of β-galactosidase/Fab immunogene is exclusively to EGF receptor-positive cells and that the herpes simplex virus thymidine kinase (TK)/Fab immunogene induces substantial suicide effects on A431 tumor cells when treated together with ganciclovir. The in vivo specificity of the immunogene transfer was examined using A431 tumor-bearing nude mice. When these nude mice were injected intraperitoneally with the chloramphenicol acetyltransferase (CAT)/Fab immunogene, CAT DNA was detected in the tumors as well as in liver and kidney but not brain, whereas CAT mRNA and enzyme activity were detected only in the tumors. Local and intraperitoneal injection of the TK/Fab immunogene and subsequent administration of ganciclovir effectively suppressed the growth of A431 tumors transplanted on the backs of nude mice. These observations suggest a possible application of the Fab immunogene system in cancer gene therapy. To target the delivery of therapeutic genes into EGF receptor-hyperproducing tumor cells, we developed the “Fab immunogene,” which is a novel gene transfer vehicle consisting of the Fab fragment of anti-human EGF receptor antibody B4G7 and poly-l-lysine, forming an affinity complex with DNA. Here, we provide evidence that the Fab immunogene specifically delivers reporter genes in vitro as well as in vivo. Moreover, delivery of the therapeutic suicide gene TK and subsequent treatment with ganciclovir efficiently suppressed the growth of A431 cell tumors transplanted in nude mice. Thus, the TK/Fab immunogene has potential for use in the in vivo systemic therapy of squamous cell carcinomas." @default.
• W1969767511 created "2016-06-24" @default.
• W1969767511 creator A5017953567 @default.
• W1969767511 creator A5036295933 @default.
• W1969767511 creator A5057857434 @default.
• W1969767511 creator A5057908958 @default.
• W1969767511 creator A5070029030 @default.
• W1969767511 creator A5085627139 @default.
• W1969767511 date "1998-12-10" @default.
• W1969767511 modified "2023-10-10" @default.
• W1969767511 title "Targeted <i>In Vivo</i> Delivery of Therapeutic Gene into Experimental Squamous Cell Carcinomas Using Anti-Epidermal Growth Factor Receptor Antibody: Immunogene Approach" @default.
• W1969767511 cites W1915558435 @default.
• W1969767511 cites W1965218063 @default.
• W1969767511 cites W1984512111 @default.
• W1969767511 cites W2003634190 @default.
• W1969767511 cites W2016138321 @default.
• W1969767511 cites W2036093970 @default.
• W1969767511 cites W2038304772 @default.
• W1969767511 cites W2046633126 @default.
• W1969767511 cites W2047460162 @default.
• W1969767511 cites W2069420031 @default.
• W1969767511 cites W2071631793 @default.
• W1969767511 cites W2085769544 @default.
• W1969767511 cites W2086274688 @default.
• W1969767511 cites W2093951180 @default.
• W1969767511 cites W2155956835 @default.
• W1969767511 cites W2216738296 @default.
• W1969767511 cites W4240724617 @default.
• W1969767511 cites W4256704256 @default.
• W1969767511 doi "https://doi.org/10.1089/hum.1998.9.18-2673" @default.
• W1969767511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9874265" @default.
• W1969767511 hasPublicationYear "1998" @default.
• W1969767511 type Work @default.
• W1969767511 sameAs 1969767511 @default.
• W1969767511 citedByCount "23" @default.
• W1969767511 countsByYear W19697675112013 @default.
• W1969767511 countsByYear W19697675112014 @default.
• W1969767511 countsByYear W19697675112020 @default.
• W1969767511 crossrefType "journal-article" @default.
• W1969767511 hasAuthorship W1969767511A5017953567 @default.
• W1969767511 hasAuthorship W1969767511A5036295933 @default.
• W1969767511 hasAuthorship W1969767511A5057857434 @default.
• W1969767511 hasAuthorship W1969767511A5057908958 @default.
• W1969767511 hasAuthorship W1969767511A5070029030 @default.
• W1969767511 hasAuthorship W1969767511A5085627139 @default.
• W1969767511 hasConcept C104317684 @default.
• W1969767511 hasConcept C111599444 @default.
• W1969767511 hasConcept C121608353 @default.
• W1969767511 hasConcept C153911025 @default.
• W1969767511 hasConcept C159047783 @default.
• W1969767511 hasConcept C159654299 @default.
• W1969767511 hasConcept C170493617 @default.
• W1969767511 hasConcept C203014093 @default.
• W1969767511 hasConcept C2522874641 @default.
• W1969767511 hasConcept C2776147627 @default.
• W1969767511 hasConcept C2776362946 @default.
• W1969767511 hasConcept C2777965375 @default.
• W1969767511 hasConcept C2779438470 @default.
• W1969767511 hasConcept C2779820661 @default.
• W1969767511 hasConcept C2781196997 @default.
• W1969767511 hasConcept C29537977 @default.
• W1969767511 hasConcept C34981463 @default.
• W1969767511 hasConcept C47170353 @default.
• W1969767511 hasConcept C502942594 @default.
• W1969767511 hasConcept C54009773 @default.
• W1969767511 hasConcept C54355233 @default.
• W1969767511 hasConcept C55493867 @default.
• W1969767511 hasConcept C67082663 @default.
• W1969767511 hasConcept C81885089 @default.
• W1969767511 hasConcept C86803240 @default.
• W1969767511 hasConceptScore W1969767511C104317684 @default.
• W1969767511 hasConceptScore W1969767511C111599444 @default.
• W1969767511 hasConceptScore W1969767511C121608353 @default.
• W1969767511 hasConceptScore W1969767511C153911025 @default.
• W1969767511 hasConceptScore W1969767511C159047783 @default.
• W1969767511 hasConceptScore W1969767511C159654299 @default.
• W1969767511 hasConceptScore W1969767511C170493617 @default.
• W1969767511 hasConceptScore W1969767511C203014093 @default.
• W1969767511 hasConceptScore W1969767511C2522874641 @default.
• W1969767511 hasConceptScore W1969767511C2776147627 @default.
• W1969767511 hasConceptScore W1969767511C2776362946 @default.
• W1969767511 hasConceptScore W1969767511C2777965375 @default.
• W1969767511 hasConceptScore W1969767511C2779438470 @default.
• W1969767511 hasConceptScore W1969767511C2779820661 @default.
• W1969767511 hasConceptScore W1969767511C2781196997 @default.
• W1969767511 hasConceptScore W1969767511C29537977 @default.
• W1969767511 hasConceptScore W1969767511C34981463 @default.
• W1969767511 hasConceptScore W1969767511C47170353 @default.
• W1969767511 hasConceptScore W1969767511C502942594 @default.
• W1969767511 hasConceptScore W1969767511C54009773 @default.
• W1969767511 hasConceptScore W1969767511C54355233 @default.
• W1969767511 hasConceptScore W1969767511C55493867 @default.
• W1969767511 hasConceptScore W1969767511C67082663 @default.
• W1969767511 hasConceptScore W1969767511C81885089 @default.
• W1969767511 hasConceptScore W1969767511C86803240 @default.
• W1969767511 hasIssue "18" @default.
• W1969767511 hasLocation W19697675111 @default.
• W1969767511 hasLocation W19697675112 @default.

• next